搜索
搜索
News
資訊分類
/
/
Breaking the monopoly of foreign patent drugs in the fields of lung cancer, leukemia and so on

Breaking the monopoly of foreign patent drugs in the fields of lung cancer, leukemia and so on

  • 分類:Company news
  • 作者:
  • 來源:
  • 發佈時間:2019-06-18 17:40
  • 訪問量:

【概要描述】Breaking the monopoly of foreign patent drugs in the fields of lung cancer, leukemia and so on

Breaking the monopoly of foreign patent drugs in the fields of lung cancer, leukemia and so on

【概要描述】Breaking the monopoly of foreign patent drugs in the fields of lung cancer, leukemia and so on

  • 分類:Company news
  • 作者:
  • 來源:
  • 發佈時間:2019-06-18 17:40
  • 訪問量:
詳情
Breaking foreign monopolies in lung cancer, leukemia and other fields, and listing of domestic small molecule targeted drugs prompted foreign drugs to reduce prices by more than 50% in China The major special achievements of national science and technology not only include 4G mobile communication and Beidou satellite navigation, but also biomedical technology innovation closely related to people's health.
The reporter learned at the achievement conference of "National Science and technology major special project for new drug creation" held by the Ministry of science and technology on the 22nd that China has broken the foreign drug monopoly in lung cancer, leukemia, drug-resistant bacteria and other fields, and the R & D innovation ability and industrial development of the biomedical industry have been continuously enhanced, achieving stage results and fruitful results.
The drug problem is related to people's life and health, and there have been painful lessons all over the world. Non clinical evaluation is an important part of the necessary stage of new drug research and development. Sang Guowei, chief engineer of special science and technology for new drug creation and academician of Chinese Academy of engineering, said that under the special support for new drug creation, the construction of non clinical evaluation platform for drugs in China has made a series of major breakthroughs, the pre clinical evaluation of new drugs has been in line with the international standards, and the core key technologies of the evaluation platform have reached the international advanced level, which strongly supports the research and development of new drugs in China and ensures the public medication.

掃二維碼用手機看

Copyright 2019 ©chinazhenlei.cn All Rights Reserved       浙ICP备17005887号

power:300.cn

Copyright 2019 ©chinazhenlei.cn

浙ICP备10036259号

网站建设: 中企动力  台州